Safety profile of vascular endothelial growth factor receptor tyrosine-kinase inhibitors in pediatrics: a pharmacovigilance disproportionality analysis

Overview of attention for article published in Frontiers in Pharmacology, June 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 9,290 followers.

RT @PVpapers: Safety Profile of Vascular Endothelial Growth Factor Receptor Tyrosine-kinase Inhibitors in Pediatrics: A Pharmacovigilance D…

16 Jun 2023

Reply Repost Favourite

Safety Profile of Vascular Endothelial Growth Factor Receptor Tyrosine-kinase Inhibitors in Pediatrics: A Pharmacovigilance Disproportionality Analysis https://t.co/AcNPMKbtY4

16 Jun 2023

Reply Repost Favourite

New Research: Safety profile of vascular endothelial growth factor receptor tyrosine-kinase inhibitors in pediatrics: a pharmacovigilance disproportionality analysis #pharmacology https://t.co/kNq0yaLlec

12 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.